Saniona
Company

Last deal

$65M

Amount

Post-IPO Equity

Stage

10.08.2020

Date

3

all rounds

$83.97M

Total amount

date founded

Financing round

General

About Company
Saniona is a research and development company focused on developing drugs for various diseases.

Industry

Sector :

Subsector :

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company's technology platform enables the investigation of all types of ion channel drug targets, with a focus on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. Its product pipeline includes Tesomet, SAN711, Tesofensine, NS2359, and CAD-1883. Saniona's most advanced product candidate, Tesomet, is in mid-stage clinical trials for rare eating disorders. The company is also advancing two product candidates, SAN711 and SAN903, for the treatment of neuropathic pain conditions and inflammatory/fibrotic disorders, respectively. Saniona has research and development partnerships with several companies and is listed on Nasdaq Stockholm Small Cap.
Contacts

Contact Email

Phone number

Social url

Similar Companies
999
Immune Control

Immune Control

Immune Control, Inc. develops serotonin-based immunotherapeutics for diseases and cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Conshohocken, PA 19428, USA

total rounds

1

total raised

$11.3M
Immuneed

Immuneed

The company operates a contract research organization focused on developing therapeutic cancer vaccines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Uppsala, Sweden

total rounds

1

total raised

$504.29K
InterMune

InterMune

InterMune researches and develops therapies for pulmonology and orphan fibrotic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Brisbane, CA, USA

total rounds

2
AKL Research & Development

AKL Research & Development

AKL Research & Development develops innovative solutions for inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Stevenage, UK

total rounds

1

total raised

$881.53K

Financials

Funding Rounds
5
3

Number of Funding Rounds

$83.97M

Money Raised

Their latest funding was raised on 10.08.2020. Their latest investor Michael J. Fox Foundation. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
28.06.2018
1
$155.15K
Local Amount - DKK 1M
29.12.2017
1
$17.6M
Local Amount - SEK 144M
RA Capital Management

RA Capital Management

RA Capital Management is a Boston-based investment advisor that specializes in the life-sciences and drug development sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Health Care, Financial Services

Location

Boston, MA, USA

count Of Investments

381

count Of Exists

33
New Leaf Venture Partners

New Leaf Venture Partners

New Leaf Venture Partners is a venture capital firm that invests in healthcare technology companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

New York, NY, USA

count Of Investments

138

count Of Exists

33
Andra AP-fonden

Andra AP-fonden

Swedish fund investing in telecom and data center startups, averaging <2 deals/year.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Employee Benefits, Finance

Location

Gothenburg, Sweden

count Of Investments

5

Third Swedish National Pension Fund

The Third Swedish National Pension Fund is a venture capital firm based in Stockholm, Sweden.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Government, Finance

Location

Stockholm, Sweden

count Of Investments

6

count Of Exists

1
Pontifax

Pontifax

Pontifax is a healthcare-dedicated venture capital firm that finances pharmaceutical and life sciences companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Herzliya, Israel

count Of Investments

97

count Of Exists

9
Innovation Fund Denmark

Innovation Fund Denmark

Innovation Fund Denmark invests in knowledge, technology, and products for societal solutions.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Copenhagen, Denmark

count Of Investments

71

count Of Exists

3
Nice & Green SA

Nice & Green SA

Nice & Green Corporate Finance Services provides growth finance to small and mid-sized listed companies.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Finance

Location

Nyon, Switzerland

count Of Investments

28

count Of Exists

4
Co-Investors
Investors
10
9

Number of lead investors

10

Number of investors

Investor 
Lead 
Round 
Partners 
Michael J. Fox Foundation

Michael J. Fox Foundation

Michael J. Fox Foundation is a non-profit research firm dedicated to finding better treatments and a cure for Parkinson's disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Financial Services, Non-Profit

Location

New York, NY, USA

count Of Investments

72

count Of Exists

5
Marco Baptista

Marco Baptista

Marco Baptista joined the MJF Foundation in 2012. As Vice President, Research Programs, Marco stays closely linked to the Parkinson's community in order to develop an aggressive and innovative agenda for accelerating research and drug development for Parkinson's disease.

current job

Michael J. Fox Foundation
Michael J. Fox Foundation
Innovation Fund Denmark

Innovation Fund Denmark

Innovation Fund Denmark invests in knowledge, technology, and products for societal solutions.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Copenhagen, Denmark

count Of Investments

71

count Of Exists

3

Australian Research Council

Australian Research Council advises government and funds competitive research grants.

Sector

Health Care Providers

Subsector

Health Care Services

count Of Investments

7

People

Founders
1
Jørgen Drejer
Jørgen Drejer

Jørgen Drejer

Jørgen Drejer is a Founder and CSO at Saniona. He Attended Danmarks Farmaceutiske Universitet.

current job

Saniona
Saniona

organization founded

1

Jørgen Drejer

Employee Profiles
6

Wendy Dwyer

Chief Business Officer

Linea Aspesi

Linea Aspesi

Chief Human Resources Officer

Jason A. Amello

Jason A. Amello

Chief Financial Officer

Rami Levin

Rami Levin

President and Chief Executive Officer

Jørgen Drejer

Jørgen Drejer

Founder and CSO

Activity

Recent News
0